Log In
Print
BCIQ
Print
Print this Print this
 

IPH 2101 (formerly NN1975)

Also known as: Anti-KIR

  Manage Alerts
Collapse Summary General Information
Company Innate Pharma S.A.
DescriptionHuman IgG4 mAb against killer cell immunoglobulin-like receptors (KIR)
Molecular Target Natural killer T cells
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$465.0M

$35.0M

$430.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today